Literature DB >> 31844169

Fibrosis in dysthyroid eye disease.

Marian Ludgate1.   

Abstract

Dysthyroid eye disease is a rare condition, mainly found in people with Graves' hyperthyroidism. Autoimmune responses to thyroid/orbit shared antigens drive extensive tissue remodelling. This includes excess adipogenesis and over-production of extra-cellular matrix, which both tend to occur in the earlier 'active' inflammatory stages of disease. With time these give way to fibrosis, which has a profound impact on eye motility and may be life-long. Progress has been made in identifying the shared autoantigen(s) and the role of specific T cells and autoantibodies in remodelling, which have facilitated development of novel therapies. However relatively little is known of the autoimmune processes under-pinning fibrosis and currently there are no adequate medical treatments.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31844169      PMCID: PMC7002441          DOI: 10.1038/s41433-019-0731-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

Review 1.  Mechanisms for the induction of autoimmunity by infectious agents.

Authors:  K W Wucherpfennig
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 2.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

3.  Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses.

Authors:  Elvira Alonso-Merino; Rosa Martín Orozco; Lidia Ruíz-Llorente; Olaia A Martínez-Iglesias; Juan Pedro Velasco-Martín; Ana Montero-Pedrazuela; Luisa Fanjul-Rodríguez; Constanza Contreras-Jurado; Javier Regadera; Ana Aranda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 4.  Insights into the role of fibroblasts in human autoimmune diseases.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.

Authors:  Sajad Moshkelgosha; Po-Wah So; Neil Deasy; Salvador Diaz-Cano; J Paul Banga
Journal:  Endocrinology       Date:  2013-07-30       Impact factor: 4.736

6.  Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.

Authors:  Sijie Fang; Yazhuo Huang; Sisi Zhong; Yangyang Li; Yidan Zhang; Yinwei Li; Jing Sun; Xingtong Liu; Yang Wang; Shuo Zhang; Tianle Xu; Xiaodong Sun; Ping Gu; Dan Li; Huifang Zhou; Bin Li; Xianqun Fan
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

7.  Autoantibodies to the IGF1 receptor in Graves' orbitopathy.

Authors:  Waldemar B Minich; Nora Dehina; Tim Welsink; Christian Schwiebert; Nils G Morgenthaler; Josef Köhrle; Anja Eckstein; Lutz Schomburg
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

8.  A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.

Authors:  Seema Kumar; Sarah Nadeem; Marius N Stan; Michael Coenen; Rebecca S Bahn
Journal:  J Mol Endocrinol       Date:  2011-04-12       Impact factor: 5.098

Review 9.  Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management.

Authors:  Jesús Barrio-Barrio; Alfonso L Sabater; Elvira Bonet-Farriol; Álvaro Velázquez-Villoria; Juan C Galofré
Journal:  J Ophthalmol       Date:  2015-08-17       Impact factor: 1.909

10.  Macrophages promote a profibrotic phenotype in orbital fibroblasts through increased hyaluronic acid production and cell contractility.

Authors:  I-Hui Yang; Geoffrey E Rose; Daniel G Ezra; Maryse Bailly
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

View more
  1 in total

Review 1.  The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.

Authors:  Jueyu Hou; Yunjing Tang; Yongjiang Chen; Danian Chen
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.